Weiguang Biological
SZSE · 002880
Market Cap$5.4B
Revenue$1.3B
Employees901
Listed OnSZSE
Ticker002880
CEO / ExecMs. Caiping Guo
HeadquartersShenzhen
MarketMainland China
Websitewww.szwg.com
Overview
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human factor VIII, human immunoglobulin (PH4), human rabies immunoglobulin, human tetanus immunoglobulin, human hepatitis B immunoglobulin, human albumin, human histaglobulin, human firbrinogen, human immunoglobulin for intravenous injection freeze-dried, lyophilized human rabies vaccine and human prothrombin complex. Shenzhen Weiguan
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.